Clinical Trial Update: KPD Consolidation After ASCT in NDMM Patients [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 2/Phase 3 study evaluating consolidation with the KPD regimen after autologous stem cell transplant in newly diagno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Decadron (Dexamethasone)
• Kyprolis (carfilzomib)
• Pomalyst (pomalidomide)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Multiple Myeloma, Newly Diagnosed | Phase 2, Phase 3 | Status: RECRUITING